Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Emerging World Pharma (EWPI) said that its strategic partner African Global Pharma (AGP) is expected to begin the trial production test runs at its manufacturing facility next week.
Subscribe to our email newsletter
AGP’s generic drug manufacturing facility recently received inspection approvals by both the Food and Drug Board of Ghana (FDB) and the Ghana Standards Board (GSB).
EWPI stated that the manufacturing process is expected to go through several phases of testing to ensure that the quality and approval standards is met.
EWPI president, Brandon Keks said that he was impressed with the manufacturing facility and its team of chemist, pharmacists and operators.
"I believe we should be on schedule to be in full production by the January 2011 target date," Keks said.
EWPI confirms that initial production of medicines will commence in December with full production and availability expected to be ready in January.